GlassScriptPhysician profile
Colleen Kelly
NPI 1407400419
$4,797.06
in general payments reported to CMS, 2019-2025
38 companies · $740 in 2025
The $740 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $665 · 2022: $517 · 2023: $2,025 · 2024: $851 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,666 · Travel and Lodging: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,666.24 |
| Travel and Lodging | $949.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,260.15 | 2023 | |
| Boston Scientific Corporation | $398.74 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $371.65 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Collegium Pharmaceutical, INC. | $355.57 | 2021-2025 | Belbuca, Nucynta |
| Abbvie INC. | $248.98 | 2022-2024 | |
| Nevro Corp. | $229.20 | 2021-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.63 | 2021-2025 | Relistor |
| Lundbeck LLC | $161.45 | 2021-2023 | Vyepti |
| Saluda Medical Americas, INC. | $110.24 | 2023-2025 | Evoke, Evoke Scs |
| Virtus Pharmaceuticals LLC | $109.64 | 2023-2025 | Levorphanol Tartrate |
| Forte Bio-Pharma LLC | $99.61 | 2022-2023 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $98.20 | 2021-2025 | Ztlido |
| Redhill Biopharma INC. | $85.23 | 2021 | |
| Spinal Simplicity, LLC | $77.89 | 2024 | Ha Minuteman G3-R |
| Azurity Pharmaceuticals, INC. | $70.62 | 2023-2025 | Horizant, Horizant, Edarbi |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.